J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 86 (2005), 2469-2480; DOI 10.1099/vir.0.81057-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viejo-Borbolla, A.
Right arrow Articles by Schulz, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viejo-Borbolla, A.
Right arrow Articles by Schulz, T. F.
Agricola
Right arrow Articles by Viejo-Borbolla, A.
Right arrow Articles by Schulz, T. F.
© 2005 Society for General Microbiology

Increase in infectivity of targeted Moloney murine leukemia virus-based gene-delivery vectors through lowering the threshold for fusion

A. Viejo-Borbolla1,2,3,{dagger}, P. Thomas2, E. D. Blair2,{ddagger} and T. F. Schulz1,3

1 Department of Medical Microbiology and Genitourinary Medicine, University of Liverpool, Liverpool, UK
2 Departments of Applied Diagnostics and Computational Chemistry, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK
3 Department of Virology, Hannover Medical School, Hannover, Germany

Correspondence
A. Viejo-Borbolla
aviejo{at}cnb.uam.es

Many research groups have developed targeted vectors for gene therapy based on Moloney murine leukemia virus (MoMLV). Despite proper binding of the targeted vector to the target molecule, little or no infectivity of human cells expressing the target molecule has been achieved in most studies. One of the reasons for this lack of infectivity may be steric hindrance within the targeted envelope glycoprotein (Env), impeding the conformational changes required for fusion and infection. Here, attempts were made to solve this problem by mutating key residues within Env of two targeted MoMLV-based vectors, MoMLV–E-Sel and MoMLV–FBP. Selection of key residues was based on an Env with reduced threshold for fusion, that of the CD4-independent human immunodeficiency virus type 2 isolate ROD/B. It was shown here that vectors bearing MoMLV–FBP Env with a V512M substitution had higher titres and faster kinetics of entry than vectors bearing parental targeted Env proteins. This could be due to the partial release of steric constraints that result in an Env with a reduced threshold for fusion.

{dagger}Present address: Dept of Molecular and Cell Biology, Centro Nacional de Biotecnología, CSIC; C/Darwin 3, 28049 Madrid, Spain.

{ddagger}Present address: Integrated Medicines Ltd, Caxton, Cambridge CB3 8PQ, UK.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 by the Society for General Microbiology.